Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guosheng Fu

Showing results (261-270 of 290) with videos related to

Pageof 29
Sort By:
Chinese Medical Journal|March 3, 2025
Cost-effectiveness of angiographic quantitative flow ratio-guided coronary intervention: A multicenter, randomized, sham-controlled trialYanyan Zhao, Changdong Guan, Yang Wang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 7, 2025
One-Year Outcomes of Novel Transcatheter Edge-to-Edge Mitral Repair System in Patients With Functional Mitral RegurgitationKai Xu, Da Zhu, Hong Jiang, et al.
Science Bulletin|January 20, 2023
2018 update of expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCIYong Huo, Young-Hoon Jeong, Yanjun Gong, et al.
JACC. Asia|March 11, 2024
Sex Differences in Clinical Outcomes Associated With Quantitative Flow Ratio-Guided Percutaneous Coronary InterventionYundai Chen, Lei Gao, Birgit Vogel, et al.
JACC. Asia|July 3, 2025
Position Statement on Antiplatelet Therapy for East Asians With Coronary Artery Disease: 2025 UpdateYanjun Gong, Young-Hoon Jeong, Tzung-Dau Wang, et al.
JACC. Cardiovascular Interventions|November 20, 2025
Rationales Behind Physiology-Guided Revascularization: Diagnostic Impact of Quantitative Flow Ratio in the FAVOR III China TrialRui Zhang, Hao-Yu Wang, Lei Song, et al.
JACC. Cardiovascular Interventions|April 15, 2026
Post-PCI Global QFR and Long-Term Outcomes in ACS: Findings From the FAVOR III China TrialXiaohua Shen, Han Zhang, Zhengwei Li, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 8, 2022
Drug-coated balloon for the treatment of small vessel disease: 9 months of angiographic results and 12 months of clinical outcomes of the PEPCAD China SVD studyJuying Qian, Yizhe Wu, Chenguang Li, et al.
BMJ Open|November 21, 2023
Early 6 months usage of single anTiplAtelet OR anTicoAgulant followed by single antiplatelet after transcatheter aortic valve replacement: protocol for a multicentre, open-label, randomised controlled clinical trialXiangming Hu, Haiyan Xu, Can Wang, et al.
JACC. Cardiovascular Interventions|December 8, 2018
Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized TrialYundai Chen, Lei Gao, Qin Qin, et al.
Pageof 29

Showing results (261-270 of 290) with videos related to

Sort By:
Pageof 29
Chinese Medical Journal|March 3, 2025
Cost-effectiveness of angiographic quantitative flow ratio-guided coronary intervention: A multicenter, randomized, sham-controlled trialYanyan Zhao, Changdong Guan, Yang Wang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 7, 2025
One-Year Outcomes of Novel Transcatheter Edge-to-Edge Mitral Repair System in Patients With Functional Mitral RegurgitationKai Xu, Da Zhu, Hong Jiang, et al.
Science Bulletin|January 20, 2023
2018 update of expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCIYong Huo, Young-Hoon Jeong, Yanjun Gong, et al.
JACC. Asia|March 11, 2024
Sex Differences in Clinical Outcomes Associated With Quantitative Flow Ratio-Guided Percutaneous Coronary InterventionYundai Chen, Lei Gao, Birgit Vogel, et al.
JACC. Asia|July 3, 2025
Position Statement on Antiplatelet Therapy for East Asians With Coronary Artery Disease: 2025 UpdateYanjun Gong, Young-Hoon Jeong, Tzung-Dau Wang, et al.
JACC. Cardiovascular Interventions|November 20, 2025
Rationales Behind Physiology-Guided Revascularization: Diagnostic Impact of Quantitative Flow Ratio in the FAVOR III China TrialRui Zhang, Hao-Yu Wang, Lei Song, et al.
JACC. Cardiovascular Interventions|April 15, 2026
Post-PCI Global QFR and Long-Term Outcomes in ACS: Findings From the FAVOR III China TrialXiaohua Shen, Han Zhang, Zhengwei Li, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 8, 2022
Drug-coated balloon for the treatment of small vessel disease: 9 months of angiographic results and 12 months of clinical outcomes of the PEPCAD China SVD studyJuying Qian, Yizhe Wu, Chenguang Li, et al.
BMJ Open|November 21, 2023
Early 6 months usage of single anTiplAtelet OR anTicoAgulant followed by single antiplatelet after transcatheter aortic valve replacement: protocol for a multicentre, open-label, randomised controlled clinical trialXiangming Hu, Haiyan Xu, Can Wang, et al.
JACC. Cardiovascular Interventions|December 8, 2018
Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized TrialYundai Chen, Lei Gao, Qin Qin, et al.
Pageof 29